The usage of mesenchymal stem cells in the treatment of type 1 diabetes mellitus
Type 1 diabetes mellitus is a metabolic disorder characterized by an autoimmune attack against the insulin producing Beta-cells of the pancreas. Also known as insulin-dependent diabetes, patients must receive exogenous injections of insulin in order to maintain glycemic homeostasis. The necessity...
Main Author: | Schulz, Andrew |
---|---|
Other Authors: | McKnight, C. James |
Language: | en_US |
Published: |
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/38696 |
Similar Items
-
Management of Type 1 diabetes mellitus with autologous mesenchymal stem cells
by: Pradeep V Mahajan, et al.
Published: (2019-01-01) -
Mesenchymal stem cell therapy in type 2 diabetes mellitus
by: Li Zang, et al.
Published: (2017-05-01) -
Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis
by: Yanju Li, et al.
Published: (2021-05-01) -
Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes?
by: Elisabetta Donzelli, et al.
Published: (2020-05-01) -
Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta‐analysis
by: Hossein Ranjbaran, et al.
Published: (2021-05-01)